Alexion Pharmaceuticals, Inc. Debt to Equity Ratio 2010-2021 | ALXN
Current and historical debt to equity ratio values for Alexion Pharmaceuticals, Inc. (ALXN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Alexion Pharmaceuticals, Inc. debt/equity for the three months ending March 31, 2021 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2021-03-31 | $6.22B | $12.43B | 0.50 |
| 2020-12-31 | $6.45B | $11.65B | 0.55 |
| 2020-09-30 | $6.47B | $11.08B | 0.59 |
| 2020-06-30 | $6.21B | $10.49B | 0.59 |
| 2020-03-31 | $6.40B | $11.75B | 0.55 |
| 2019-12-31 | $6.27B | $11.27B | 0.56 |
| 2019-09-30 | $4.45B | $10.37B | 0.43 |
| 2019-06-30 | $4.40B | $10.16B | 0.43 |
| 2019-03-31 | $4.29B | $9.71B | 0.44 |
| 2018-12-31 | $4.77B | $9.17B | 0.52 |
| 2018-09-30 | $4.67B | $9.17B | 0.51 |
| 2018-06-30 | $4.72B | $8.77B | 0.54 |
| 2018-03-31 | $4.72B | $9.11B | 0.52 |
| 2017-12-31 | $4.69B | $8.89B | 0.53 |
| 2017-09-30 | $4.70B | $8.94B | 0.53 |
| 2017-06-30 | $4.61B | $8.88B | 0.52 |
| 2017-03-31 | $4.58B | $8.86B | 0.52 |
| 2016-12-31 | $4.56B | $8.69B | 0.52 |
| 2016-09-30 | $4.79B | $8.50B | 0.56 |
| 2016-06-30 | $4.83B | $8.20B | 0.59 |
| 2016-03-31 | $4.74B | $8.06B | 0.59 |
| 2015-12-31 | $4.84B | $8.26B | 0.59 |
| 2015-09-30 | $4.90B | $8.25B | 0.59 |
| 2015-06-30 | $4.62B | $8.55B | 0.54 |
| 2015-03-31 | $0.90B | $3.52B | 0.26 |
| 2014-12-31 | $0.90B | $3.30B | 0.27 |
| 2014-09-30 | $0.77B | $3.12B | 0.25 |
| 2014-06-30 | $0.67B | $2.88B | 0.23 |
| 2014-03-31 | $0.68B | $2.70B | 0.25 |
| 2013-12-31 | $0.94B | $2.38B | 0.39 |
| 2013-09-30 | $0.70B | $2.36B | 0.30 |
| 2013-06-30 | $0.60B | $2.21B | 0.27 |
| 2013-03-31 | $0.60B | $2.09B | 0.29 |
| 2012-12-31 | $0.64B | $1.97B | 0.33 |
| 2012-09-30 | $0.63B | $1.87B | 0.34 |
| 2012-06-30 | $0.71B | $1.75B | 0.41 |
| 2012-03-31 | $0.80B | $1.21B | 0.66 |
| 2011-12-31 | $0.26B | $1.13B | 0.23 |
| 2011-09-30 | $0.25B | $1.06B | 0.24 |
| 2011-06-30 | $0.23B | $0.95B | 0.24 |
| 2011-03-31 | $0.25B | $0.90B | 0.28 |
| 2010-12-31 | $0.15B | $0.86B | 0.18 |
| 2010-09-30 | $0.13B | $0.81B | 0.16 |
| 2010-06-30 | $0.10B | $0.79B | 0.12 |
| 2010-03-31 | $0.09B | $0.74B | 0.13 |
| 2009-12-31 | $0.10B | $0.69B | 0.14 |
| 2009-09-30 | $0.13B | $0.43B | 0.29 |
| 2009-06-30 | $0.13B | $0.39B | 0.33 |
| 2009-03-31 | $0.22B | $0.28B | 0.79 |
